Yahoo Web Search

Search results

    • Clene (NASDAQ: CLNN) Issues Update on NIH-Funded Program for CNM-Au8(R) in ALS

      Digital Journal· 6 hours ago

      ...subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, has announced several key updates on its National Institutes of Health ("NIH") funded Accelerating Access...